Search

everythinglearnresearchcommunity

for

Search:↓

Most cases were lichen planus pigmentosus, highlighting the need for accurate diagnosis for proper treatment.

Accurate diagnosis is key for treating different kinds of hair loss, and immune response variations may affect the condition and treatment results.

Using drugs to activate the Wnt/β-catenin pathway has potential for treating diseases but also presents challenges.

Current treatments for hair loss from chemotherapy are limited, but new methods are being researched.

Ethosomes can safely and effectively deliver various drugs deep into the skin.

CCT128930 is a promising new drug that effectively targets and inhibits a cancer-related protein, showing potential for cancer treatment.

New patents show progress in developing drugs targeting the Wnt pathway for diseases like cancer and hair loss.

Targeted drug delivery to pancreatic beta-cells can improve type 2 diabetes treatment.

A new device, IVL-PPF Microsphere®, was created to deliver a hair loss drug for up to 3 months with one injection, potentially replacing daily pills.

Selective androgen receptor modulators (SARMs) are a promising type of drug for various health conditions due to their targeted actions.

New drug dutasteride effectively treats hair loss, but use cautiously due to potential sexual side effects.

Liposomes show promise in cancer treatment by delivering drugs with less toxicity and improved effectiveness.

The ethosomal delivery system improves topical drug delivery and promotes hair growth.

Microneedles are promising for long-acting drug delivery and can improve patient compliance, but more data is needed to confirm their effectiveness.

New drugs face challenges due to limited evidence, and safety updates are advised for some existing medications.

Drug repurposing finds new uses for existing drugs, saving time and money.

Liposomes improve drug delivery and reduce skin irritation in dermatology.

The drug enzalutamide may reduce the ability of the virus causing COVID-19 to enter lung cells.

Two drugs, ritlecitinib and brepocitinib, improved scalp hair loss condition markers.

Different drug doses approved in Japan and the U.S. are not mainly due to different clinical responses, and ethnic factors should be considered in setting drug doses.

Cancer treatment drugs can cause permanent hair loss by damaging hair follicle stem cells, but a specific inhibitor might reverse this effect.

A drug helped quickly reduce a movement disorder, experts debated the severity of Raynaud phenomenon, and rapid weight loss was linked to temporary hair loss with good recovery.

The drug showed promise in treating renal cell carcinoma with manageable side effects.

Certain leukemia drugs can cause severe skin reactions that may require stopping treatment.

Drugs for hormone-related conditions might help treat mental disorders but could have serious side effects.

Dobutamine does not mimic dopamine at therapeutic doses but may at very high concentrations; microfilaments, not microtubules, are important for wound healing in Xenopus embryos.

A synthetic drug and a South American herb may help treat alopecia areata in Chinese men.

New treatments may restore cancer-blocking proteins, slow prostate cancer, identify drug targets, and potentially regrow hair.

Cannabinoid and steroid-based drugs could be new treatments for Tourette syndrome, but more research is needed to confirm their effectiveness and safety.

Potential therapeutic targets for scarring hair loss are identified.